Is Novartis ethical?

What Choice found

Choice can get this wrong — tell us if something's off.

1–5 of 5

Manufacturing Confirmed

Novartis opens cancer drug facility in Carlsbad

Novartis opened a new 10,000-square-foot manufacturing facility in Carlsbad to produce cancer drugs as part of a $23 billion U.S. investment plan.

2 sourcesRead sources
latimes.com
Swiss drugmaker Novartis opened a new 10,000-square-foot manufacturing facility in Carlsbad to make cancer drugs, as part of its promised $23 billion investment push to build out its domestic U.S. facilities over the next five years.
swissinfo.ch
This content was published on Apr 30, 2026 Novartis is expanding its production capacity in the United States, with the announcement of a new site in Morrisville, North Carolina. This plant will bring to seven the number of new sites planned as part of its $23 billion investment plan.

Manufacturing Confirmed

Novartis opens seventh U.S. plant

Novartis opens seventh plant in the United States, Keystone-SDA.

1 sourceRead sources
swissinfo.ch
Novartis opens seventh plant in the United States Keystone-SDA

Manufacturing Confirmed

Novartis invests $23B in U.S. manufacturing and R&D

Novartis plans a $23B investment over five years to expand its U.S. manufacturing and R&D operations.

1 sourceRead sources
finance.yahoo.com
Novartis plans to expand its US-based manufacturing and R&D footprint with a total investment of $23B over the next 5 years

Ukraine & Russia Confirmed

Novartis engages with Ukraine emergency teams

Novartis is engaged with the Ukraine Country NEM team and its employees to monitor the situation and provide security guidance and support services.

1 sourceRead sources
business-humanrights.org
...The global Novartis Emergency Management (NEM) team is engaged closely with the Ukraine Country NEM team and Novartis employees on a continuous basis to monitor and assess the situation on-ground and provide employees with security guidance and support services including:

Ukraine & Russia Confirmed

Novartis follows similar steps by drugmakers

Novartis takes similar steps as other drugmakers after sanctions against Moscow for its invasion of Ukraine.

1 sourceRead sources
finance.yahoo.com
The move by Novartis follows similar steps by other drugmakers following sanctions against Moscow for its invasion of Ukraine.